- Category
- Micro (2020-21)
- Udyam number
- UDYAM-MH-33-0073607

About Rejoym Biotech Private Limited
Data last updated:
Rejoym Biotech Private Limited is a private limited company based in Mira Road, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 March 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24290MH2021PTC357243.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Santosh Shrinath Pandey and Hariom Shri Nath Pandey.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Office No – 103 Bldg No – B/69 Nitin Shanti Nagar Chs.Ltd Sector – 1, Mira Road, Maharashtra, India – 401107.
As per the financials filed for FY 2024, the company reported a revenue of ₹32.9 Lakh, a growth of 60% compared to the previous year. For the same year it recorded a net loss of ₹1.33 Lakh (net margin -4%) and EBITDA of -₹1.33 Lakh (EBITDA margin -4%).
Rejoym Biotech Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0073607). For more details, the company can be reached via its website rejoymbiotech.com.
Company details
Recognitions & Rankings of Rejoym Biotech
Contact details
Rejoym Biotech Private Limited's registered office is in Mira Road, Maharashtra. Its website is rejoymbiotech.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressOffice No – 103 Bldg No – B/69 Nitin Shanti Nagar Chs.Ltd Sector – 1, Mira Road, Maharashtra, India – 401107
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Rejoym Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Rejoym Biotech is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Rejoym Biotech Private Limited, buy the company report.
Financials of Rejoym Biotech Private Limited
FY 2024 filings availableRejoym Biotech Private Limited reported revenue of ₹32.9 Lakh (up 60% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 60% in the latest year. EBITDA rose 87% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹1.33 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹1.33 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -4% | |||
| Net Profit Margin | -4% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Rejoym Biotech Private Limited, buy the company report.
Board of directors of Rejoym Biotech Private Limited
Rejoym Biotech has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Santosh Shrinath Pandey | Director | 17 Mar 2021 | 5 Years 7 Months | Current |
| Hariom Shri Nath Pandey Also directs: Mediccon Lifecare Private Limited | Director | 17 Mar 2021 | 5 Years 7 Months | Current |
Peer comparison
Rejoym Biotech Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Glorious Healthcare Private Limited | ₹33.03 Lakh (FY 2024) | -24.0% | Indore, Madhya Pradesh, India | |||
| Mellow Pharmaceuticals Private Limited | ₹33 Lakh (FY 2022) | 17.0% | New Delhi, Delhi, India | |||
| Asolear Aesthetics Private Limited | ₹32.95 Lakh (FY 2024) | -7.0% | New Delhi, Delhi, India | |||
| Unipick Biotech Private Limited | ₹32.92 Lakh (FY 2025) | 58.0% | Indore, Madhya Pradesh, India | |||
| Nhyoda Pharmaceuticals Private Limited | ₹32.92 Lakh (FY 2023) | Pune, Maharashtra, India | ||||
| Rejoym Biotech Private Limitedthis company | ₹32.9 Lakh (FY 2024) | -₹1.33 Lakh | -4% | 60.0% | Mira Road, Maharashtra, India | |
| Av Max Lub Private Limited | ₹32.88 Lakh (FY 2025) | 38.0% | Udupi, Karnataka, India | |||
| Genexis Biotech Private Limited | ₹32.88 Lakh (FY 2024) | 15.0% | Vadodara, Gujarat, India | |||
| Protein Design Private Limited | ₹32.87 Lakh (FY 2024) | 31.0% | Bangalore, Karnataka, India | |||
| Filix Organics Private Limited | ₹32.86 Lakh (FY 2018) | 85.0% | Hyderabad, Telangana, India | |||
| Normo Helth Private Limited | ₹32.84 Lakh (FY 2025) | -23.0% | Jalgaon, Maharashtra, India |
To see the full peer comparison of Rejoym Biotech Private Limited, buy the company report.
Auditor
Rejoym Biotech Private Limited is audited by D J A D & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| D J A D & CO. | FY 2023 | 150689W |
Shareholding
The shareholding of Rejoym Biotech Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Rejoym Biotech Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Rejoym Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rejoym Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Rejoym Biotech Private Limited has 1 active EPFO establishment as of Apr 05, 2024.
GST
No GST registration is on our record for Rejoym Biotech Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Rejoym Biotech Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Hariom Shri Nath Pandey was appointed as Director on 17 Mar 2021.
Frequently asked questions
Rejoym Biotech is an active private limited company based in Mira Road, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 March 2021 (5+ years old) and is registered under CIN U24290MH2021PTC357243.
Rejoym Biotech has 2 current directors:
- Santosh Shrinath Pandey - Director
- Hariom Shri Nath Pandey - Director
The latest financial statements of Rejoym Biotech on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Rejoym Biotech is U24290MH2021PTC357243. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rejoym Biotech was incorporated on 17 March 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Rejoym Biotech by revenue are Glorious Healthcare Private Limited, Mellow Pharmaceuticals Private Limited, Asolear Aesthetics Private Limited, Unipick Biotech Private Limited, Nhyoda Pharmaceuticals Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Hariom Shri Nath Pandey was appointed as Director on 17 Mar 2021. Santosh Shrinath Pandey was appointed as Director on 17 Mar 2021.
Yes, Rejoym Biotech is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-33-0073607).
Rejoym Biotech can be reached through the website rejoymbiotech.com. Its registered office is in Mira Road, Maharashtra, India.
The registered office of Rejoym Biotech is at Office No – 103 Bldg No – B69 Nitin Shanti Nagar Chs.Ltd Sector – 1, Mira Road, Maharashtra, India – 401107.
Rejoym Biotech operates in the pharma industry, in the drug formulation and development segment.

